Key result
TRUST-AMI biomarker model achieves ~1.00 ROC-AUC for diagnosing acute myocardial infarction.
Why the study?
Machine-learning cardiovascular risk scores often suffer from silent data leakage, absent calibration analysis, and lack of clinician involvement in defining outcomes, rendering models with near-perfect discrimination unusable at the bedside.
Does the leakage-audited, calibration-aware TRUST-AMI machine-learning framework accurately rule in and rule out acute myocardial infarction from routine bedside biomarkers and ECGs compared to standard single-threshold troponin rules and cardiologist adjudication?
Observational (n=1,319)
Blinded outcome adjudication for a random 15% subset
Yes
Does the leakage-audited, calibration-aware TRUST-AMI machine-learning framework accurately rule in and rule out acute myocardial infarction from routine bedside biomarkers and ECGs compared to standard single-threshold troponin rules and cardiologist adjudication?
Enforcing strict data-leakage prevention, calibration auditing, and dataset deduplication demonstrates that while biomarker-driven machine learning achieves high discrimination for acute myocardial infarction (ROC-AUC 0.996), its incremental gain over a simple troponin threshold is clinically modest (+0.071 AUC) and unvetted public ECG datasets can catastrophically inflate acute-MI F1 scores from 0.121 to 0.998 due to duplicate images.
Answers are grounded in this paper and cite their sources.
High discrimination in audited cohort supports leakage-aware ML methods; leaves open incremental utility over troponin thresholds in prospective triage.
Machine-learning risk scores for cardiovascular disease are proliferating, yet independent appraisals repeatedly find the same three defects: silent data leakage, an absent calibration analysis, and no clinician involvement in defining the outcome being predicted. A model can therefore report a near-perfect area under the curve and still be unusable at the bedside. This paper presents TRUST-AMI, a leakage-audited, calibration-aware, and explainable approach for one narrowly scoped and time-critical decision: the rapid rule-in and rule-out of acute myocardial infarction (AMI) from routinely collected cardiac biomarkers, supported by a separately audited electrocardiogram (ECG) imaging branch. A cohort of 1,319 emergency presentations (positive = 810, negative = 509) described by eight bedside variables was analysed under a protocol in which imputation and scaling are fitted inside cross-validation folds, model selection uses 5-fold stratified cross-validation on the training partition alone, and the held-out test set (n = 264) is scored exactly once. Four classifiers were compared across calibration, clinical operating characteristics, 1,000-sample bootstrap intervals, ablation, decision-curve analysis, and sex and age subgroup analysis. The selected random forest attained a test ROC-AUC of 0.996 (95% CI 0.988–1.000), sensitivity 1.000, specificity 0.961, and agreement with the cardiologist reference of κ = 0.968. The ECG branch, trained on PTB-XL under patient-disjoint folds, reached a test ROC-AUC of 0.908 (n = 1,517) with Grad-CAM supplying waveform-level evidence. A second, clinically validated four-class ECG image corpus was audited before use, and the audit is itself a result: its 928 released files contain 491 distinct images and 311 distinct patients, and 87.4% of the acute-MI class consists of byte-identical copies. Holding estimator, features, and corpus fixed and varying only what the partition may share, macro-F1 falls from 0.969 to 0.656 and acute-MI F1 from 0.998 to 0.121. The resulting tool is an AMI triage aid within coronary heart disease and is not presented as a general cardiovascular-disease diagnoser. All code, seeds, and results are released publicly, and the study is offered as a reproducible template for reporting clinical prediction models transparently.
No takes yet. Share an insight, caveat, or question.
Ikechukwu et al. (2026) conducted an observational in Acute Myocardial Infarction (n=1,319). TRUST-AMI (Random Forest biomarker classifier and Grad-CAM ECG branch) vs. Cardiologist reference standard (Fourth Universal Definition of Myocardial Infarction) and single-threshold troponin rule was evaluated on Test set discrimination (ROC-AUC) for acute myocardial infarction rule-in and rule-out (ROC-AUC 0.996 (Sensitivity 1.000, Specificity 0.961, Cohen's kappa 0.968; +0.071 AUC gain over single-threshold troponin rule), 95% CI 0.988-1.000). The TRUST-AMI random forest biomarker model achieved a test ROC-AUC of 0.996, sensitivity of 1.000, and specificity of 0.961 for diagnosing acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: